IDH1 and pilocytic astrocytoma: IDH mutations can be used intracranially as both a diagnostic marker to distinguish diffuse from pilocytic astrocytomas, given its rare incidence in pilocytic astrocytomas, and as a prognostic marker, with IDH-mutant tumors having a more favorable prognosis compared to wild-type tumors (115, 117).